TrialPloS one2016
DAAs Rapidly Reduce Inflammation but Increase Serum VEGF Level: A Rationale for Tumor Risk during Anti-HCV Treatment.
Rosanna Villani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
67 papers cite itlatest 60 shown
this paperpooled ittrialcites it